Clinical investigation of medicinal products for treatment of migraine - Scientific guideline

This document provides guidance on the clinical development of new medicinal products in the treatment of migraine.

Keywords: Migraine, acute migraine, chronic migraine, migraine prophylaxis

Current effective version

Guideline on clinical investigation of medicinal products for the treatment of migraine

Adopted Reference Number: CPMP/EWP/788/01 Rev. 1 Legal effective date: 31/07/2007

English (EN) (66.73 KB - PDF)

Esmakordselt avaldatud: 24/01/2007 Viimati ajakohastatud: 24/01/2007

Concept paper on the need for revision of the guideline on clinical investigation of medicinal product for the treatment of migraine

Draft: consultation closed Consultation dates: 21/10/2016 to 31/01/2017 Reference Number: EMA/CHMP/179671/2016

English (EN) (84.58 KB - PDF)

Esmakordselt avaldatud: 21/10/2016 Viimati ajakohastatud: 21/10/2016

Guideline on clinical investigation of medicinal products for the treatment of migraine

Adopted Reference Number: CPMP/EWP/788/01 Rev. 1 Legal effective date: 31/07/2007

English (EN) (66.73 KB - PDF)

Esmakordselt avaldatud: 24/01/2007 Viimati ajakohastatud: 24/01/2007

Overview of comments received on draft guideline on clinical investigation of medicinal products for the treatment of migraine

Reference Number: EMEA/CHMP/EWP/21477/2007

English (EN) (56.57 KB - PDF)

Esmakordselt avaldatud: 24/01/2007 Viimati ajakohastatud: 24/01/2007

Draft guideline on clinical investigation of medicinal products for the treatment of migraine

Draft: consultation closed Reference Number: CPMP/EWP/788/01 Rev. 1

English (EN) (77.46 KB - PDF)

Esmakordselt avaldatud: 26/01/2006 Viimati ajakohastatud: 26/01/2006